Ocid-D Capsule is a combination pharmaceutical formulation containing Domperidone 10 mg and Omeprazole 20 mg, designed for the management of gastrointestinal disorders. Domperidone, a peripheral dopamine D2 receptor antagonist, enhances gastrointestinal motility by accelerating gastric emptying and improving esophageal sphincter tone, thereby alleviating symptoms such as nausea, vomiting, and bloating. Omeprazole, a proton pump inhibitor, suppresses gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase enzyme system in the gastric parietal cells, providing effective relief from acid-related conditions including gastroesophageal reflux disease (GERD), peptic ulcers, and erosive esophagitis. The combination of these agents offers a synergistic therapeutic effect, addressing both delayed gastric emptying and excessive acid production. Ocid-D Capsule is indicated for symptomatic treatment of acid reflux associated with impaired motility and acid hypersecretion. It is generally well tolerated; however, caution is advised in patients with known hypersensitivity to either component, hepatic impairment, or underlying cardiac conditions. The medication should be administered as prescribed by a healthcare professional, typically before meals to optimize efficacy. Regular monitoring and adherence to prescribed dosage are essential to minimize potential adverse effects and ensure optimal therapeutic outcomes.